Cellect Biotechnology Ltd (APOP.OQ)
APOP.OQ on NASDAQ Stock Exchange Capital Market
7.07USD
4:00pm EDT
7.07USD
4:00pm EDT
Change (% chg)
$-0.08 (-1.12%)
$-0.08 (-1.12%)
Prev Close
$7.15
$7.15
Open
$7.13
$7.13
Day's High
$7.13
$7.13
Day's Low
$7.07
$7.07
Volume
2
2
Avg. Vol
4,271
4,271
52-wk High
$13.50
$13.50
52-wk Low
$6.12
$6.12
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Mar '18 | 0.00 | -0.028 |
| FY 2017 | Dec '17 | ||
| Jun '17 | 0.00 | -0.042 | |
| Mar '17 | 0.00 | -0.137 | |
| FY 2016 | Dec '16 | 0.00 | -0.021 |
| Sep '16 | 0.00 | -0.071 | |
| Jun '16 | 0.00 | -0.039 | |
| Mar '16 | 0.00 | -0.049 |
*Note: Units in Millions ofShekel
**Note: Units in Shekel
Consensus Estimates Analysis
No consensus analysis data available.
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 235.76 | 33.88 | |
| P/E High - Last 5 Yrs. | -- | 288.75 | 47.66 | |
| P/E Low - Last 5 Yrs. | -- | 99.96 | 25.18 | |
| Beta | 2.09 | 0.73 | 0.78 | |
| Price to Sales (TTM) | -- | 260.48 | 8.30 | |
| Price to Book (MRQ) | 7.74 | 23.31 | 4.32 | |
| Price to Tangible Book (MRQ) | 6.82 | 30.41 | 5.99 | |
| Price to Cash Flow (TTM) | -- | 138.67 | 22.70 | |
| % Owned Institutions | -- | 11.74 | 2.41 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.33 | 1.69 | |
| Dividend Yield - 5 Year Avg | -- | 0.20 | 1.42 | |
| Dividend 5 Year Growth Rate | -- | 2.20 | -6.64 | |
| Payout Ratio(TTM) | -- | 41.81 | 40.53 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -- | 24.25 | 5.00 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -- | 136.30 | 12.65 | |
| Sales - 5 Yr. Growth Rate | -- | 30.91 | 7.92 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 79.39 | -78.19 | 40.28 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 46.44 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 48.46 | 8.01 | |
| Capital Spending - 5 Yr. Growth Rate | 80.20 | 36.01 | 7.43 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.67 | 2.55 |
| Current Ratio (MRQ) | 11.01 | 6.32 | 3.64 |
| LT Debt to Equity (MRQ) | 0.00 | 22.16 | 12.89 |
| Total Debt to Equity (MRQ) | 0.00 | 26.56 | 17.35 |
| Interest Coverage (TTM) | -2.86 | -139.50 | 35.70 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 56.80 | 54.88 | |
| Gross Margin - 5 Yr. Avg. | -- | 55.31 | 52.82 | |
| EBITD Margin (TTM) | -- | -- | -- | |
| EBITD - 5 Yr. Avg | -- | -166.28 | 15.78 | |
| Operating Margin (TTM) | -- | -923.67 | -0.49 | |
| Operating Margin - 5 Yr. Avg. | -- | -179.82 | 11.04 | |
| Pre-Tax Margin (TTM) | -- | -813.20 | 1.49 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | -183.43 | 11.21 | |
| Net Profit Margin (TTM) | -- | -806.44 | -1.80 | |
| Net Profit Margin - 5 Yr. Avg. | -- | -182.19 | 7.56 | |
| Effective Tax Rate (TTM) | -- | 15.36 | 29.88 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 19.24 | 24.11 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 21,567,119 | 743,658,643 | |
| Net Income/Employee (TTM) | -- | -160,062 | 86,499,502 | |
| Receivable Turnover (TTM) | -- | 18.13 | 6.06 | |
| Inventory Turnover (TTM) | -- | 2.87 | 3.64 | |
| Asset Turnover (TTM) | 0.00 | 0.48 | 0.88 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -58.41 | -3.67 | 10.40 | |
| Return on Assets - 5 Yr. Avg. | -77.20 | -0.80 | 11.13 | |
| Return on Investment (TTM) | -64.02 | -5.45 | 13.21 | |
| Return on Investment - 5 Yr. Avg. | -87.94 | 2.04 | 14.44 | |
| Return on Equity (TTM) | -86.58 | -6.94 | 15.18 | |
| Return on Equity - 5 Yr. Avg. | -96.80 | -3.02 | 15.79 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -- | -- | -- |
| EPS (TTM) % | -49.97 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Cellect Biotechnology Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.